Podoplanin is a novel antibody-based therapeutic target for glioblastoma
Publication
, Conference
Kato, Y; Mishima, K; Kaneko, M; Zalutsky, M; Kuan, C-T; Bigner, D
Published in: CANCER RESEARCH
May 1, 2009
Duke Scholars
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
May 1, 2009
Volume
69
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kato, Y., Mishima, K., Kaneko, M., Zalutsky, M., Kuan, C.-T., & Bigner, D. (2009). Podoplanin is a novel antibody-based therapeutic target for glioblastoma. In CANCER RESEARCH (Vol. 69). AMER ASSOC CANCER RESEARCH.
Kato, Yukinari, Kazuhiko Mishima, Mika Kaneko, Michael Zalutsky, Chien-Tsun Kuan, and Darell Bigner. “Podoplanin is a novel antibody-based therapeutic target for glioblastoma.” In CANCER RESEARCH, Vol. 69. AMER ASSOC CANCER RESEARCH, 2009.
Kato Y, Mishima K, Kaneko M, Zalutsky M, Kuan C-T, Bigner D. Podoplanin is a novel antibody-based therapeutic target for glioblastoma. In: CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2009.
Kato, Yukinari, et al. “Podoplanin is a novel antibody-based therapeutic target for glioblastoma.” CANCER RESEARCH, vol. 69, AMER ASSOC CANCER RESEARCH, 2009.
Kato Y, Mishima K, Kaneko M, Zalutsky M, Kuan C-T, Bigner D. Podoplanin is a novel antibody-based therapeutic target for glioblastoma. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH; 2009.
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
May 1, 2009
Volume
69
Publisher
AMER ASSOC CANCER RESEARCH
Related Subject Headings
- Oncology & Carcinogenesis
- 1112 Oncology and Carcinogenesis